
Med-Tech Startups Survive SVB Collapse but Face New Concerns
While only time will tell how bad the ultimate damage turns out to be, it appears for now at least that the industry has dodged a bullet.
While only time will tell how bad the ultimate damage turns out to be, it appears for now at least that the industry has dodged a bullet.
Cost cutting and restructuring has become the order of the day for many lab companies.
Economic volatility and uncertainty is also making a significant impact on merger and acquisition activity in the diagnostics space.
Factors to consider when determining if the concierge business model is best for your laboratory.
...